News | March 13, 2025
Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
The product will be marketed by Dr. Reddy's
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
The company disclosed that several employees of a subsidiary had their business email addresses stolen
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Subscribe To Our Newsletter & Stay Updated
